From the Division of Cancer Epidemiology and Genetics (Drs Karami, Stewart, Chow, Rothman, and Moore), National Cancer Institute, NIH, DHHS, Bethesda, Md; International Agency for Research on Cancer (Drs Boffetta and Brennan), Lyon, France; The Tisch Cancer Institute (Dr Boffetta), Mount Sinai School of Medicine, New York; International Prevention Research Institute (Dr Boffetta), Lyon, France; Stewart Exposure Assessments (Dr Stewart), LLC, Arlington, Va, and Formerly of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Md; Institute of Carcinogenesis (Dr Matveev), Cancer Research Centre, Moscow, Russia; Department of Preventive Medicine (Drs Janout and Kollarova), Faculty of Medicine, Palacky University, Olomouc, Czech Republic; Institute of Hygiene and Epidemiology (Dr Bencko), First Faculty of Medicine Charles University, Prague, Czech Republic; Department of Cancer Epidemiology and Genetics (Dr Navratilova), Masaryk Memorial Cancer Institute, Brno, Czech Republic; Department of Epidemiology (Dr Szeszenia-Dabrowska), Nofer Institute of Occupational Medicine, Lodz, Poland; The National Institute of Public Health (Dr Mates), Bucharest, Romania; Department of Chemical Hazards (Dr Gromiec), Nofer Institute of Occupational Medicine, Lodz, Poland; and Department of Urology (Dr Sobotka), First Faculty of Medicine Charles University and General Teaching Hospital, Prague, Czech Republic.
Sara Karami, PhD, MPH, National Cancer Institute, Division of Cancer Epidemiology & Genetics, Occupational and Environmental Epidemiology Branch, 6120 Executive Blvd, EPS 8121, Rockville, MD 20852; E-mail: [email protected].
